Cold chain: difference between revisions
Diff·revision 71 → 72·21:45, 18 Oct 2025
Difference between revision 71 and revision 72 of Cold chain. 2 lines changed; the page grew by 339 bytes.
| Revision 71 — 20:13, 6 Oct 2025 StateBoardStace (talk) add short description 25,931 bytes ±0 | Revision 72 — 21:45, 18 Oct 2025 CustomsClarke (talk) add DOI 26,270 bytes +339 | ||
|---|---|---|---|
| 163 | The World Health Organization's model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products, published as Annex 9 to Technical Report Series 961, performs a similar function internationally and is written to be adoptable by national regulators. It is accompanied by technical supplements addressing individual operations — refrigerated storage, temperature mapping, qualification of shippers, and monitoring — that are the closest thing to a practical manual in the public literature.{{r|whotrs961}} | 163 | The World Health Organization's model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products, published as Annex 9 to Technical Report Series 961, performs a similar function internationally and is written to be adoptable by national regulators. It is accompanied by technical supplements addressing individual operations — refrigerated storage, temperature mapping, qualification of shippers, and monitoring — that are the closest thing to a practical manual in the public literature.{{r|whotrs961}} |
| 164 | 164 | ||
| + | 165 | USP <1079> approaches the same ground from the compendial side, describing risks in storage and transport and mitigation strategies, and it is the chapter in which mean kinetic temperature and the treatment of excursions are elaborated for United States practice. USP <1118> covers the monitoring devices themselves.{{r|usp1079,usp1118}} | |
| + | 166 | ||
| 165 | == References == | 167 | == References == |
| 166 | {{reflist}} | 168 | {{reflist}} |